about
Adjuvanted vaccines in pregnancy: no evidence for effect of the adjuvanted H1N1/09 vaccination on occurrence of preeclampsia or intra-uterine growth restriction.The OptiMUM-study: EMDR therapy in pregnant women with posttraumatic stress disorder after previous childbirth and pregnant women with fear of childbirth: design of a multicentre randomized controlled trial.Disproportionate Intrauterine Growth Intervention Trial At Term: DIGITATInduction of labour versus expectant monitoring in women with pregnancy induced hypertension or mild preeclampsia at term: the HYPITAT trial.Assessment of perinatal outcome after sustained tocolysis in early labour (APOSTEL-II trial).Pessaries in multiple pregnancy as a prevention of preterm birth: the ProTwin Trial.10-Year cardiovascular event risks for women who experienced hypertensive disorders in late pregnancy: the HyRAS study.IMproving PArticipation of patients in Clinical Trials--rationale and design of IMPACTCost-effectiveness of recurrence risk guided care versus care as usual in women who suffered from early-onset preeclampsia including HELLP syndrome in their previous pregnancy (the PreCare study)Increased postpartum haemorrhage, the possible relation with serotonergic and other psychopharmacological drugs: a matched cohort study.Systematic review and metaanalysis on nonclassic cardiovascular biomarkers after hypertensive pregnancy disorders.Development and Measurement of Guidelines-Based Quality Indicators of Caesarean Section Care in the Netherlands: A RAND-Modified Delphi Procedure and Retrospective Medical Chart ReviewPredictive Factors for Delivery within 7 Days after Successful 48-Hour Treatment of Threatened Preterm Labor.Cervical pessaries for the prevention of preterm birth: a systematic reviewCervical length measurement for the prediction of preterm birth in symptomatic women with a twin pregnancy: a systematic review and meta-analysis.Spontaneous adrenal haemorrhage in early pregnancy.Porphyromonas Gingivalis and E-coli induce different cytokine production patterns in pregnant women.Pulmonary hypertension in a pregnant patient with thyrotoxicosis due to Graves' disease: considerations with respect to treatment.Early enteral tube feeding in optimizing treatment of hyperemesis gravidarum: the Maternal and Offspring outcomes after Treatment of HyperEmesis by Refeeding (MOTHER) randomized controlled trial.Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes: a randomized controlled trial.Plasma factors in severe early-onset preeclampsia do not substantially alter endothelial gene expression in vitro.Outcome of Multifetal Pregnancy Reduction in Women with a Dichorionic Triamniotic Triplet Pregnancy to a Singleton Pregnancy: A Retrospective Nationwide Cohort Study.Blood pressure patterns in women with gestational hypertension or mild preeclampsia at term.Homocysteinemia After Hypertensive Pregnancy Disorders at Term.Prediction of progression to severe disease in women with late preterm hypertensive disorders of pregnancy.Involving women in personalised decision-making on mode of delivery after caesarean section: the development and pilot testing of a patient decision aid.Cytokine production induced by non-encapsulated and encapsulated Porphyromonas gingivalis strains.High blood pressure six weeks postpartum after hypertensive pregnancy disorders at term is associated with chronic hypertension.Caesarean section rates and adverse neonatal outcomes after induction of labour versus expectant management in women with an unripe cervix: a secondary analysis of the HYPITAT and DIGITAT trials.Prediction of Time to Delivery Week-by-Week in Women with a Triplet Pregnancy.Plasma of pregnant and preeclamptic women activates monocytes in vitro.Severe endocarditis and open-heart surgery during pregnancy.Cervical pessaries to prevent preterm birth in women with a multiple pregnancy: a per-protocol analysis of a randomized clinical trial.Maternal and neonatal outcomes of pregnancy in women with chronic hypertension: a retrospective analysis of a national register.PP087. Multicenter external validation and recalibration of a model for preconceptional prediction of recurrent early-onset preeclampsia.PP077. New prognostic marker for the risk to develop early-onset preeclampsia.PP112. Prediction of preeclampsia based on clinical risk factors: A prospective high-risk cohort study.Clinical risk factors for gestational hypertensive disorders in pregnant women at high risk for developing preeclampsia.An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT-II).Multicenter impact analysis of a model for predicting recurrent early-onset preeclampsia: A before-after study.
P50
Q30371728-61F66D2F-1BC4-4573-B3C7-CBB33A4D179CQ30841470-FD1531A7-79F9-4F58-9F74-C5629A6B56CAQ33290476-5FBF3BD2-15FD-4396-A997-692E24686FE2Q33292245-F6F18388-95C6-4B7A-B284-7C99C28AB256Q33500872-11556C54-6E5B-444E-9D1B-F14AA0DA2120Q33504426-FA6CA9C1-46D3-478A-863B-E722DDB09A36Q33591844-0EA6F3F9-A1AB-478F-8660-99BB25B4363DQ33704487-3DB885EE-F982-4E70-9388-B4B319DB1FB6Q33713398-D7EFDDD5-B123-4139-ABD9-305DAA00B00FQ33759359-02F1D14D-51AA-4158-8FEF-B2163D26F959Q35122645-BFD8F9A3-9EA5-40C0-AB53-97AF5F6B22F7Q35897424-0AC45829-2874-4508-A601-0F428737BED4Q36156506-CC4BFD4C-3BD5-42F1-9B74-DDDA22B3C950Q36772540-9460E96E-6DCB-4A1B-BAD1-7858402284A7Q36882782-2E642348-9FAB-4E24-8A9A-D4BB62CEA9B5Q37146079-B17130E8-551F-4242-B9E8-C7958B8FF738Q37505673-920945C9-93C7-41F2-8514-C13137D8D141Q37588425-C0332B3D-7D8E-4418-9F18-8F73B5AC7362Q38399201-1BC08332-A0F9-4F5E-AE24-10A19A62AB3FQ38458609-ACF135BB-F82D-4226-A7FD-F9CA0D236919Q38520978-922A9D01-B9D1-42C2-AA64-EADF63521720Q38672175-C8F0E4C2-FA02-449E-BDA1-60EEEF83155EQ38994003-04B3D09B-42EF-4BBD-9DEE-4D5176AB66BEQ38996228-7BBAB0A6-5C77-47E8-A695-05E611FC7F3FQ39238730-3AA4FCC7-AD2A-4B53-A45A-83EA306B2D6DQ39283759-57298090-0040-4E23-8C33-424E3AC3DD20Q39295611-8A3CA320-F41E-48E8-A5AA-C8ADC55B1BC9Q39343400-2A8BC5F5-DD5E-4D95-B284-9A2B347419E3Q39771239-477A11B1-C24C-4B79-B516-FA3D66E05609Q39775556-09E689C1-2D3E-4DD9-BE65-C7CF8535A57BQ40009729-1ED6F49A-6168-4831-81FE-305338164150Q40078712-3B21D697-4DC2-4433-B4C1-9596B7CAE904Q40111627-146B708F-2416-47A3-88E2-942C11B468D1Q40581904-D5BCFF2F-C121-428D-BC23-12C91B6392EFQ40803809-62498099-1718-452C-A42A-0CDD13DA6473Q40803871-E328545A-9E50-4057-B0B5-38A9F71BAE75Q40804922-121F5429-9E20-426E-8B61-B5C63500BEFFQ40806961-B8A70DD4-FF29-466B-BEF4-995458A3E2F8Q40858287-3CA9A661-5713-4DF8-A1B4-86B2EB203704Q40917024-681CB755-2834-4938-938D-FDBCE2D07F25
P50
description
researcher ORCID ID = 0000-0002-3020-8908
@en
wetenschapper
@nl
name
Maria G van Pampus
@ast
Maria G van Pampus
@en
Maria G van Pampus
@es
Maria G van Pampus
@nl
type
label
Maria G van Pampus
@ast
Maria G van Pampus
@en
Maria G van Pampus
@es
Maria G van Pampus
@nl
prefLabel
Maria G van Pampus
@ast
Maria G van Pampus
@en
Maria G van Pampus
@es
Maria G van Pampus
@nl
P108
P31
P496
0000-0002-3020-8908